Safety and effectiveness of dual therapy for Helicobacter pylori infection and the effect on the glycated hemoglobin level in type 2 diabetes
Abstract Patients with diabetes have a high risk of failure of H. pylori eradication therapy. The present study aims to evaluate the efficacy and safety of vonoprazan–amoxicillin (VA) dual therapy for the treatment of H. pylori infection in patients with type-2 diabetes mellitus (T2DM), and determin...
Saved in:
| Main Authors: | Jie Zhang, Xin Cao, Kai Ma, Yizhou Jiang, Xiangrong Qin, Xiaoyong Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-85628-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and Pharmacological Aspects of Resistance to Eradication Therapy of Helicobacter Pylori Infection
by: S. Yu. Serebrova, et al.
Published: (2020-05-01) -
Biological Cost of Helicobacter pylori Rifampicin Resistance
by: K. T. Momynaliev, et al.
Published: (2020-05-01) -
Effectiveness of 14-day high-dose dual therapy for Helicobacter pylori infection in Vietnam
by: Nam T Phan, et al.
Published: (2025-03-01) -
New Approaches to Therapy of Helicobacter pylori Infection (by the Materials of the Maastricht Consensus-IV, Florence, 2010)
by: A. G. Evdokimova, et al.
Published: (2020-05-01) -
Prospective Multicenter Surveillance of Non–H. pylori Helicobacter Infections during Medical Checkups, Japan
by: Kengo Tokunaga, et al.
Published: (2025-06-01)